The authors and contributors of Patent Docs wish their readers and families a Happy Holidays! It is also our hope that all of our readers, along with their families and friends, stay safe during the holiday. Publication of Patent Docs will resume on December 27th.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Docs on Twitter
Recent Posts
- FDA Approves Lantus® Interchangeable Biosimilar
- Pharmacyclics LLC v. Alvogen, Inc. (Fed. Cir. 2022)
- Conference & CLE Calendar
- IPO Webinar on Enablement and Written Description
- Webinar on Valuing Intellectual Property
- FCBA Program on PTAB Ten Years After
- Webinar on Unified Patent Court
- USPTO Training Session on Patent Eligibility
- IPO Webinar on Ethics Issues in IP
- IPO Webinar on AI and Machine Learning for IP Enforcement
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« Board of Regents of the University of Texas System v. Baylor College of Medicine (Fed. Cir. 2020) | Main | Eli Lilly & Co. v. Apotex, Inc. (Fed. Cir. 2020) »
December 24, 2020
The comments to this entry are closed.
November 2022
Categories
- Best Mode (2)
- Biosimilars (241)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (273)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (97)
- Conferences & CLE's (2873)
- Court Report (507)
- Damages (37)
- Definiteness (25)
- District Court (214)
- Double Patenting (30)
- Enablement (33)
- Federal Circuit (958)
- Food and Drug Administration (102)
- Hatch-Waxman (87)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (24)
- Infringement - Literal or DOE (86)
- Injunction (33)
- International IP (286)
- Inventorship (15)
- Licensing (129)
- Media Commentary (64)
- Miscellaneous (159)
- News from Abroad (102)
- Novelty (69)
- Obviousness (212)
- Patent Exhaustion (3)
- Patent Legislation (304)
- Patent Litigation (216)
- Patent Office Rules & Procedures (808)
- Patent Profiles (104)
- Patent Prosecution (93)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (350)
- Patentable Subject Matter (626)
- Personalized Medicine (5)
- Post-Grant Proceedings (155)
- PTAB Report (9)
- Study/Report (6)
- Supreme Court (238)
- Tools (5)
- Trade Secrets (10)
- Utility (4)
- Venue (11)
- Written Description (81)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Comments